Zhang Zhenyu, Wang Wenhua, Yu Feng, Kwok Sze Chai, Wang Yuhai, Yin Jia
Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai China.
Department of Neurosurgery, 960 Hospital of The People's Liberation Army of China, Jinan, China.
Front Surg. 2022 Jul 28;9:930261. doi: 10.3389/fsurg.2022.930261. eCollection 2022.
Epidermoid cysts (ECs) are one of the most common causes of secondary trigeminal neuralgia (TGN). However, most previous studies have primarily focused on whether complete tumor resection was achieved, and few studies have discussed the primary goal of pain relief.
The present study provides intraoperative strategies for trigeminal nerve (TN) management in patients with TGN secondary to an EC and observed long-term follow-up outcomes.
A total of 69 patients with TGN secondary to an EC at our hospitals were included (January 2011-June 2021). The same surgical team performed all surgeries using a retrosigmoid approach. After EC removal, different methods for TN management were used, including microvascular decompression (MVD), sharp capsulectomy, nerve combing and embedded cholesterol crystal excision. The epidemiological, clinical, and surgical data were extracted.
The total EC removal rate was 92.8% (64/69). All patients achieved initial pain relief postoperatively, and 12 patients (17.4%) experienced varying degrees of hemifacial hypesthesia, which was relieved within 3-6 months. Three patients (4.3%) reported partial pain recurrence within a median follow-up period of 5.5 (0.5-10.5) years, which was relieved completely after low-dose carbamazepine administration.
The primary goal of surgical tumor removal for patients with TGN secondary to an EC is relief of the main symptom of tormenting pain. The selection of an appropriate strategy for TN, including MVD, sharp capsulectomy, nerve combing or embedded cholesterol crystal excision, should depend on the patient's situation.
表皮样囊肿(ECs)是继发性三叉神经痛(TGN)最常见的病因之一。然而,以往大多数研究主要关注肿瘤是否完全切除,很少有研究讨论缓解疼痛这一主要目标。
本研究提供了针对ECs继发TGN患者三叉神经(TN)管理的术中策略,并观察长期随访结果。
纳入我院69例ECs继发TGN的患者(2011年1月至2021年6月)。同一手术团队采用乙状窦后入路进行所有手术。切除ECs后,采用不同的TN管理方法,包括微血管减压术(MVD)、锐性囊壁切除术、神经梳理术和埋藏胆固醇结晶切除术。提取流行病学、临床和手术数据。
ECs完全切除率为92.8%(64/69)。所有患者术后均实现了初始疼痛缓解,12例患者(17.4%)出现不同程度的面部感觉减退,在3 - 6个月内缓解。3例患者(4.3%)在中位随访期5.5(0.5 - 10.5)年时报告有部分疼痛复发,低剂量卡马西平治疗后完全缓解。
ECs继发TGN患者手术切除肿瘤的主要目标是缓解折磨人的疼痛这一主要症状。选择合适的TN策略,包括MVD、锐性囊壁切除术、神经梳理术或埋藏胆固醇结晶切除术,应取决于患者的具体情况。